<DOC>
	<DOCNO>NCT01016145</DOCNO>
	<brief_summary>The objective study evaluate predictor response antipsychotic medication subject schizophrenia . The investigator evaluate psychopathology , brain MRI , genetics neuropsychological profile . Two group treatment compare : first generation antipsychotic vs. second generation antipsychotic . Participants randomize one group . Trial duration : 12 week .</brief_summary>
	<brief_title>Identifying Predictors Response Antipsychotics Using Treatment Algorithm</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Chlorpromazine</mesh_term>
	<criteria>Schizophrenia schizoaffective disorder Age : 1845 year olde Less 10 year diagnosis Acute exacerbation psychotic symptom Use clozapine Clinical unstable disease Delirium cognitive disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>predictor response</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>18-45 year old</keyword>
	<keyword>non-refractory</keyword>
</DOC>